Prevalence and Risk Factors of Reduced Bone Mineral Density in Systemic Lupus Erythematosus Patients: A Meta-Analysis

被引:19
作者
Xia, Jumei [1 ,2 ]
Luo, Ran [1 ]
Guo, Shuiming [1 ]
Yang, Yi [1 ]
Ge, Shuwang [1 ]
Xu, Gang [1 ]
Zeng, Rui [1 ]
机构
[1] Huazhong Univ Sci & Technol, Tongji Hosp, Dept Nephrol, Affiliated Tongji Med Coll, 1095 Jie Fang Ave, Wuhan 430030, Hubei, Peoples R China
[2] PLA 474 Hosp, Dept Nephrol, Urumqi 830000, Peoples R China
基金
中国国家自然科学基金;
关键词
VERTEBRAL FRACTURES; PREMENOPAUSAL WOMEN; DISEASE-ACTIVITY; DEXAMETHASONE; OSTEOBLASTS; PREDICTORS; CALCIUM; COHORT; MASS;
D O I
10.1155/2019/3731648
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Background. We aimed to conduct a meta-analysis concerning the frequency and risk factors of reduced bone mineral density (BMD) in systemic lupus erythematosus (SLE) with evidence from published studies. Methods. A comprehensive literature search was conducted based on the EMBASE, Web of Science, PubMed, and Cochrane Library databases up to March 5th, 2017. Eligible studies reported any prevalence of reduced BMD in SLE patients. All risk factors with odds ratios or risk ratios associated with reduced BMD were extracted. Results. 71 reports with 33527 SLE patients were included. Low BMD, osteopenia, and osteoporosis at any site were presented, respectively, in 45%, 38%, and 13% of the SLE patients. The prevalence of osteoporosis increased with the advancing of age, while U-shaped associations between age and the prevalence of low BMD and osteopenia were found. Lumbar spine was indicated to have higher prevalence of osteoporosis. Age, disease duration, drugs use, and many other factors were identified as predictors of reduced BMD. Conclusion. Low BMD, osteoporosis, and osteopenia appeared to be prevalent in patients with SLE. Risk factors of reduced BMD were various.
引用
收藏
页数:10
相关论文
共 51 条
[1]   Bone mineral density and carotid atherosclerosis in systemic lupus erythematosus: a controlled cross-sectional study [J].
Ajeganova, Sofia ;
Gustafsson, Thomas ;
Jogestrand, Tomas ;
Frostegard, Johan ;
Hafstrom, Ingiald .
ARTHRITIS RESEARCH & THERAPY, 2015, 17
[2]   The importance of inflammation and vitamin D status in SLE-associated osteoporosis [J].
Alele, Jimmy D. ;
Kamen, Diane L. .
AUTOIMMUNITY REVIEWS, 2010, 9 (03) :137-139
[3]   CYTOKINE PROFILE IN SYSTEMIC LUPUS-ERYTHEMATOSUS, RHEUMATOID-ARTHRITIS, AND OTHER RHEUMATIC DISEASES [J].
ALJANADI, M ;
ALBALLA, S ;
ALDALAAN, A ;
RAZIUDDIN, S .
JOURNAL OF CLINICAL IMMUNOLOGY, 1993, 13 (01) :58-67
[4]   Prevalence and risk factors of osteoporosis in female SLE patients - extended report [J].
Almehed, K. ;
d'Elia, H. Forsbad ;
Kvisti, G. ;
Ohlsson, C. ;
Carlsten, H. .
RHEUMATOLOGY, 2007, 46 (07) :1185-1190
[5]   Prevalence and risk factors of vertebral compression fractures in female SLE patients [J].
Almehed, Katarina ;
Hetenyi, Szabolcs ;
Ohlsson, Claes ;
Carlsten, Hans ;
Forsblad-d'Elia, Helena .
ARTHRITIS RESEARCH & THERAPY, 2010, 12 (04)
[6]  
Banno S, 2002, Mod Rheumatol, V12, P323, DOI 10.3109/s101650200057
[7]   RANKL and OPG gene polymorphisms: associations with vertebral fractures and bone mineral density in premenopausal systemic lupus erythematosus [J].
Bonfa, A. C. ;
Seguro, L. P. C. ;
Caparbo, V. ;
Bonfa, E. ;
Pereira, R. M. R. .
OSTEOPOROSIS INTERNATIONAL, 2015, 26 (05) :1563-1571
[8]   Current controversies in bone densitometry [J].
Bonnick, SL .
CURRENT OPINION IN RHEUMATOLOGY, 2002, 14 (04) :416-420
[9]   Bone mineral density changes in women with systemic lupus erythematosus [J].
Boyanov, M ;
Robeva, R ;
Popivanov, P .
CLINICAL RHEUMATOLOGY, 2003, 22 (4-5) :318-323
[10]   Elevated risk of clinical fractures and associated risk factors in patients with systemic lupus erythematosus versus matched controls: a population-based study in the United Kingdom [J].
Bultink, I. E. M. ;
Harvey, N. C. ;
Lalmohamed, A. ;
Cooper, C. ;
Lems, W. F. ;
van Staa, T. P. ;
de Vries, F. .
OSTEOPOROSIS INTERNATIONAL, 2014, 25 (04) :1275-1283